Yee Soo Chae

机构：Kyungpook National University Hospital, Kyungpook National University Chilgok Hospital

发表论文 305 篇 · 总被引 7677 次 · h-index 37

代表论文

• Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer (2025 · New England Journal of Medicine · 被引 55)
• Trastuzumab deruxtecan (T-DXd) + pertuzumab (P) vs taxane + trastuzumab + pertuzumab (THP) for first-line (1L) treatment of patients (pts) with human epidermal growth factor receptor 2–positive (HER2+) advanced/metastatic breast cancer (a/mBC): Interim results from DESTINY-Breast09. (2025 · Journal of Clinical Oncology · 被引 31)
• Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial (2026 · Annals of Oncology · 被引 12)
• First-line datopotamab deruxtecan (Dato-DXd) vs chemotherapy in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC) for whom immunotherapy was not an option: Additional efficacy endpoints from the TROPION-Breast02 study. (2026 · Journal of Clinical Oncology · 被引 2)
• Abstract P4-04-28: PF-07248144, a first-in-class KAT6 inhibitor, in patients with HR+ HER2− metastatic breast cancer: Updated results from phase 1 dose expansion study (2025 · Clinical Cancer Research · 被引 2)
• Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+ advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. (2025 · Journal of Clinical Oncology · 被引 2)